Publisert 23.07.2019

Canadian Patent - Notice of Allowance

Canadian Patent - Notice of Allowance

The Canadian Patent Office has issued a notice of allowance of additional US patent on Regenics technology. The patent is entitled: "USE OF CELLULAR EXTRACTS FOR SKIN REJUVENATION"

CA Patent Application No. 2,894,448

CA National Phase Entry of PCT/IB2013/003177

Int’l Filing Date: 06-Dec-2013 

Entitled: USE OF CELLULAR EXTRACTS FOR SKIN REJUVENATION

 For more info, please contact Henrik Lund at henrik.lund@regenics.no or mobile +47 90971219

 

Regenics AS has developed a number of assays and techniques to study effects of various substances on skin cells both in vitroin vivo and in the clinic. Our focus is to develop products and techniques for therapeutic skin applications and to improve skin appearance.